MSInsight is empowering precision medicine in oncology by revealing actionable information on microsatellite instability - MSI - through genomic analysis.
Location: France, Ile-of-France, Paris
Total raised: $1.74M
Investors 1
| Date | Name | Website |
| 02.02.2022 | Agoranov | agoranov.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.03.2025 | Seed | $1.74M | - |
Mentions in press and media 4
| Date | Title | Description |
| 13.03.2025 | MSInsight Secures €1.6 Million to Transform Cancer Diagnostics | In the heart of Paris, a startup is on a mission to revolutionize cancer diagnostics. MSInsight has successfully raised €1.6 million in Seed funding, a significant step toward redefining how microsatellite instability (MSI) cancers are diag... |
| 12.03.2025 | MSInsight secures €1.6 million to redefine MSI cancer diagnosis | Paris-based MSInsight, a startup innovating precision medicine solutions in oncology, has closed a €1.6 million Seed funding round to accelerate the development and regulatory approval of MSIcare, its AI-powered diagnostic software designed... |
| 10.03.2025 | MSInsight Raises €1.6M in Seed Funding | MSInsight, a Paris, France-based startup specializing in precision medicine in oncology, raised €1.6M in Seed funding. Backers included Calyseed, with participation from Plateau de Saclay Business Angels, Yes Invest, Capital Cell, and banki... |
| - | MSInsight | “Empowering precision oncology by unlocking insights on MSI via Next-Generation Sequencing for better tumor biomarker diagnosis and improved patient care.” |